Use in SpecificPopulations: Pediatricuse described___________________________________Dosage Form andStrengths: Oralsuspension___________________________________Indications and Usage:Antibiotic___________________________________Dosage Form andStrengths: Injection___________________________________Drug Abuse andDependence: Risk forDependence___________________________________Dosage Form andStrengths: OrallyDisintegrating Tablet___________________________________Dosage Form andStrengths: Sprinkle___________________________________Indications and Usage:Hypertension___________________________________Indications and Usage:Seizure, Epilepsy___________________________________Drug Interactions:Interaction withamiodarone___________________________________Contraindications,Warnings, andPrecautions: Risk ofQT prolongation___________________________________Indications and Usage:Combination Therapy___________________________________Adverse Reactions:May cause nausea___________________________________Indications and Usage:Pain___________________________________Contraindications,Warnings, andPrecautions: Risk of C.difficile infection___________________________________Adverse Reactions:May cause headache___________________________________Patient CounselingInformation: Advisesuse of contraception___________________________________Dosage Form andStrengths: Topical___________________________________Drug Interactions:CYP3A4 inducer___________________________________Drug Interactions:CYP3A4 substrate___________________________________Use in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarning___________________________________Adverse Reactions:10+ Adverse Reactionslisted___________________________________Patient CounselingInformation: Containsmissed doseinstructions___________________________________Free!Contraindications,Warnings, andPrecautions: Risk ofnephrotoxicity___________________________________Drug Abuse andDependence:Schedule IV ControlledSubstance___________________________________Dosage Form andStrengths: Oralsolution___________________________________Dosage andAdministration: Twice-daily dosing___________________________________Use in SpecificPopulations: Geriatricuse described___________________________________Drug Interactions:CYP2C9 substrate___________________________________Patient CounselingInformation: Adviseslimiting sun exposure___________________________________Drug Interactions:Interaction withwarfarin___________________________________Drug Abuse andDependence:Schedule II ControlledSubstance___________________________________Drug Interactions:CYP2D6 inhibitor___________________________________Indications and Usage:Antiviral___________________________________Indications and Usage:ADHD___________________________________Drug Interactions:Interaction withgrapefruit___________________________________Contraindications,Warnings, andPrecautions: Risk ofsevere rash___________________________________Adverse Reactions:May cause weight loss___________________________________Dosage Form andStrengths: Extended-release formulation___________________________________Dosage Form andStrengths: Oralcapsule___________________________________Dosage Form andStrengths: Oral tablet___________________________________Indications and Usage:has 3+ FDA-approvedindications___________________________________Dosage Form andStrengths:Transdermal patch___________________________________Patient CounselingInformation: Advisesavoiding alcoholconsumption___________________________________Patient CounselingInformation: Advisesseparation frommultivitamins___________________________________Use in SpecificPopulations: Notrecommended duringpregnancy___________________________________How Supplied/Storageand Handling: Store atroom temperature___________________________________Adverse Reactions:May causedrowsiness/sedation___________________________________Dosage Form andStrengths: Delayed-release formulation___________________________________Use in SpecificPopulations: Hepaticimpairment usedescribed___________________________________Drug Interactions:CYP2D6 substrate___________________________________Contraindications,Warnings, andPrecautions: Black BoxWarning___________________________________Dosage andAdministration: Doseadjustment required forrenal impairment___________________________________How Supplied/Storageand Handling: Protectfrom light___________________________________Drug Interactions:CYP3A4 inhibitor___________________________________Indications and Usage:Diabetes___________________________________How Supplied/Storageand Handling:Refrigeration required___________________________________Indications and Usage:Anticoagulant___________________________________Indications and Usage:Depression___________________________________Adverse Reactions:May cause weight gain___________________________________Contraindications,Warnings, andPrecautions: Risk ofhypoglycemia___________________________________Contraindications,Warnings, andPrecautions: Risk ofbleeding___________________________________Use in SpecificPopulations: Renalimpairment usedescribed___________________________________Patient CounselingInformation: Must takewith food___________________________________Contraindications,Warnings, andPrecautions: Risk ofrespiratory depression___________________________________Drug Interactions:CYP2C9 inhibitor___________________________________Dosage andAdministration: Once-daily dosing___________________________________Dosage andAdministration: Weeklydosing___________________________________Patient CounselingInformation: Advisesagainst driving oroperating heavymachinery___________________________________Dosage andAdministration: Doseadjustment required forhepatic impairment___________________________________Indications and Usage:Immunization___________________________________Use in SpecificPopulations: Notrecommended duringlactation___________________________________Contraindications,Warnings, andPrecautions: Risk ofhepatotoxicity___________________________________Contraindications,Warnings, andPrecautions: Risk ofserotonin syndrome___________________________________Use in SpecificPopulations: Pediatricuse described___________________________________Dosage Form andStrengths: Oralsuspension___________________________________Indications and Usage:Antibiotic___________________________________Dosage Form andStrengths: Injection___________________________________Drug Abuse andDependence: Risk forDependence___________________________________Dosage Form andStrengths: OrallyDisintegrating Tablet___________________________________Dosage Form andStrengths: Sprinkle___________________________________Indications and Usage:Hypertension___________________________________Indications and Usage:Seizure, Epilepsy___________________________________Drug Interactions:Interaction withamiodarone___________________________________Contraindications,Warnings, andPrecautions: Risk ofQT prolongation___________________________________Indications and Usage:Combination Therapy___________________________________Adverse Reactions:May cause nausea___________________________________Indications and Usage:Pain___________________________________Contraindications,Warnings, andPrecautions: Risk of C.difficile infection___________________________________Adverse Reactions:May cause headache___________________________________Patient CounselingInformation: Advisesuse of contraception___________________________________Dosage Form andStrengths: Topical___________________________________Drug Interactions:CYP3A4 inducer___________________________________Drug Interactions:CYP3A4 substrate___________________________________Use in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarning___________________________________Adverse Reactions:10+ Adverse Reactionslisted___________________________________Patient CounselingInformation: Containsmissed doseinstructions___________________________________Free!Contraindications,Warnings, andPrecautions: Risk ofnephrotoxicity___________________________________Drug Abuse andDependence:Schedule IV ControlledSubstance___________________________________Dosage Form andStrengths: Oralsolution___________________________________Dosage andAdministration: Twice-daily dosing___________________________________Use in SpecificPopulations: Geriatricuse described___________________________________Drug Interactions:CYP2C9 substrate___________________________________Patient CounselingInformation: Adviseslimiting sun exposure___________________________________Drug Interactions:Interaction withwarfarin___________________________________Drug Abuse andDependence:Schedule II ControlledSubstance___________________________________Drug Interactions:CYP2D6 inhibitor___________________________________Indications and Usage:Antiviral___________________________________Indications and Usage:ADHD___________________________________Drug Interactions:Interaction withgrapefruit___________________________________Contraindications,Warnings, andPrecautions: Risk ofsevere rash___________________________________Adverse Reactions:May cause weight loss___________________________________Dosage Form andStrengths: Extended-release formulation___________________________________Dosage Form andStrengths: Oralcapsule___________________________________Dosage Form andStrengths: Oral tablet___________________________________Indications and Usage:has 3+ FDA-approvedindications___________________________________Dosage Form andStrengths:Transdermal patch___________________________________Patient CounselingInformation: Advisesavoiding alcoholconsumption___________________________________Patient CounselingInformation: Advisesseparation frommultivitamins___________________________________Use in SpecificPopulations: Notrecommended duringpregnancy___________________________________How Supplied/Storageand Handling: Store atroom temperature___________________________________Adverse Reactions:May causedrowsiness/sedation___________________________________Dosage Form andStrengths: Delayed-release formulation___________________________________Use in SpecificPopulations: Hepaticimpairment usedescribed___________________________________Drug Interactions:CYP2D6 substrate___________________________________Contraindications,Warnings, andPrecautions: Black BoxWarning___________________________________Dosage andAdministration: Doseadjustment required forrenal impairment___________________________________How Supplied/Storageand Handling: Protectfrom light___________________________________Drug Interactions:CYP3A4 inhibitor___________________________________Indications and Usage:Diabetes___________________________________How Supplied/Storageand Handling:Refrigeration required___________________________________Indications and Usage:Anticoagulant___________________________________Indications and Usage:Depression___________________________________Adverse Reactions:May cause weight gain___________________________________Contraindications,Warnings, andPrecautions: Risk ofhypoglycemia___________________________________Contraindications,Warnings, andPrecautions: Risk ofbleeding___________________________________Use in SpecificPopulations: Renalimpairment usedescribed___________________________________Patient CounselingInformation: Must takewith food___________________________________Contraindications,Warnings, andPrecautions: Risk ofrespiratory depression___________________________________Drug Interactions:CYP2C9 inhibitor___________________________________Dosage andAdministration: Once-daily dosing___________________________________Dosage andAdministration: Weeklydosing___________________________________Patient CounselingInformation: Advisesagainst driving oroperating heavymachinery___________________________________Dosage andAdministration: Doseadjustment required forhepatic impairment___________________________________Indications and Usage:Immunization___________________________________Use in SpecificPopulations: Notrecommended duringlactation___________________________________Contraindications,Warnings, andPrecautions: Risk ofhepatotoxicity___________________________________Contraindications,Warnings, andPrecautions: Risk ofserotonin syndrome___________________________________

BINGO Rx - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
  1. Use in Specific Populations: Pediatric use described _________________ __________________
  2. Dosage Form and Strengths: Oral suspension _________________ __________________
  3. Indications and Usage: Antibiotic _________________ __________________
  4. Dosage Form and Strengths: Injection _________________ __________________
  5. Drug Abuse and Dependence: Risk for Dependence _________________ __________________
  6. Dosage Form and Strengths: Orally Disintegrating Tablet _________________ __________________
  7. Dosage Form and Strengths: Sprinkle _________________ __________________
  8. Indications and Usage: Hypertension _________________ __________________
  9. Indications and Usage: Seizure, Epilepsy _________________ __________________
  10. Drug Interactions: Interaction with amiodarone _________________ __________________
  11. Contraindications, Warnings, and Precautions: Risk of QT prolongation _________________ __________________
  12. Indications and Usage: Combination Therapy _________________ __________________
  13. Adverse Reactions: May cause nausea _________________ __________________
  14. Indications and Usage: Pain _________________ __________________
  15. Contraindications, Warnings, and Precautions: Risk of C. difficile infection _________________ __________________
  16. Adverse Reactions: May cause headache _________________ __________________
  17. Patient Counseling Information: Advises use of contraception _________________ __________________
  18. Dosage Form and Strengths: Topical _________________ __________________
  19. Drug Interactions: CYP3A4 inducer _________________ __________________
  20. Drug Interactions: CYP3A4 substrate _________________ __________________
  21. Use in Specific Populations: Has reproductive toxicity/teratogenicity warning _________________ __________________
  22. Adverse Reactions: 10+ Adverse Reactions listed _________________ __________________
  23. Patient Counseling Information: Contains missed dose instructions _________________ __________________
  24. Free!
  25. Contraindications, Warnings, and Precautions: Risk of nephrotoxicity _________________ __________________
  26. Drug Abuse and Dependence: Schedule IV Controlled Substance _________________ __________________
  27. Dosage Form and Strengths: Oral solution _________________ __________________
  28. Dosage and Administration: Twice-daily dosing _________________ __________________
  29. Use in Specific Populations: Geriatric use described _________________ __________________
  30. Drug Interactions: CYP2C9 substrate _________________ __________________
  31. Patient Counseling Information: Advises limiting sun exposure _________________ __________________
  32. Drug Interactions: Interaction with warfarin _________________ __________________
  33. Drug Abuse and Dependence: Schedule II Controlled Substance _________________ __________________
  34. Drug Interactions: CYP2D6 inhibitor _________________ __________________
  35. Indications and Usage: Antiviral _________________ __________________
  36. Indications and Usage: ADHD _________________ __________________
  37. Drug Interactions: Interaction with grapefruit _________________ __________________
  38. Contraindications, Warnings, and Precautions: Risk of severe rash _________________ __________________
  39. Adverse Reactions: May cause weight loss _________________ __________________
  40. Dosage Form and Strengths: Extended-release formulation _________________ __________________
  41. Dosage Form and Strengths: Oral capsule _________________ __________________
  42. Dosage Form and Strengths: Oral tablet _________________ __________________
  43. Indications and Usage: has 3+ FDA-approved indications _________________ __________________
  44. Dosage Form and Strengths: Transdermal patch _________________ __________________
  45. Patient Counseling Information: Advises avoiding alcohol consumption _________________ __________________
  46. Patient Counseling Information: Advises separation from multivitamins _________________ __________________
  47. Use in Specific Populations: Not recommended during pregnancy _________________ __________________
  48. How Supplied/Storage and Handling: Store at room temperature _________________ __________________
  49. Adverse Reactions: May cause drowsiness/sedation _________________ __________________
  50. Dosage Form and Strengths: Delayed-release formulation _________________ __________________
  51. Use in Specific Populations: Hepatic impairment use described _________________ __________________
  52. Drug Interactions: CYP2D6 substrate _________________ __________________
  53. Contraindications, Warnings, and Precautions: Black Box Warning _________________ __________________
  54. Dosage and Administration: Dose adjustment required for renal impairment _________________ __________________
  55. How Supplied/Storage and Handling: Protect from light _________________ __________________
  56. Drug Interactions: CYP3A4 inhibitor _________________ __________________
  57. Indications and Usage: Diabetes _________________ __________________
  58. How Supplied/Storage and Handling: Refrigeration required _________________ __________________
  59. Indications and Usage: Anticoagulant _________________ __________________
  60. Indications and Usage: Depression _________________ __________________
  61. Adverse Reactions: May cause weight gain _________________ __________________
  62. Contraindications, Warnings, and Precautions: Risk of hypoglycemia _________________ __________________
  63. Contraindications, Warnings, and Precautions: Risk of bleeding _________________ __________________
  64. Use in Specific Populations: Renal impairment use described _________________ __________________
  65. Patient Counseling Information: Must take with food _________________ __________________
  66. Contraindications, Warnings, and Precautions: Risk of respiratory depression _________________ __________________
  67. Drug Interactions: CYP2C9 inhibitor _________________ __________________
  68. Dosage and Administration: Once-daily dosing _________________ __________________
  69. Dosage and Administration: Weekly dosing _________________ __________________
  70. Patient Counseling Information: Advises against driving or operating heavy machinery _________________ __________________
  71. Dosage and Administration: Dose adjustment required for hepatic impairment _________________ __________________
  72. Indications and Usage: Immunization _________________ __________________
  73. Use in Specific Populations: Not recommended during lactation _________________ __________________
  74. Contraindications, Warnings, and Precautions: Risk of hepatotoxicity _________________ __________________
  75. Contraindications, Warnings, and Precautions: Risk of serotonin syndrome _________________ __________________